Cargando…

Prediction of Molecular Initiating Events for Adverse Outcome Pathways Using High-Throughput Identification of Chemical Targets

The impact of exposure to multiple chemicals raises concerns for human and environmental health. The adverse outcome pathway method offers a framework to support mechanism-based assessment in environmental health starting by describing which mechanisms are triggered upon interaction with different s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lizano-Fallas, Veronica, Carrasco del Amor, Ana, Cristobal, Susana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9965981/ https://www.ncbi.nlm.nih.gov/pubmed/36851063 http://dx.doi.org/10.3390/toxics11020189

Ejemplares similares

Nonionic Surfactants can Modify the Thermal Stability of Globular and Membrane Proteins Interfering with the Thermal Proteome Profiling Principles to Identify Protein Targets
por: Berlin, Emmanuel, et al.
Publicado: (2023)

Prediction of the Neurotoxic Potential of Chemicals Based on Modelling of Molecular Initiating Events Upstream of the Adverse Outcome Pathways of (Developmental) Neurotoxicity
por: Gadaleta, Domenico, et al.
Publicado: (2022)

Application of Bioactive Thermal Proteome Profiling to Decipher the Mechanism of Action of the Lipid Lowering 13(2)-Hydroxy-pheophytin Isolated from a Marine Cyanobacteria
por: Carrasco del Amor, Ana, et al.
Publicado: (2019)

In Silico Molecular Docking and In Vivo Validation with Caenorhabditis elegans to Discover Molecular Initiating Events in Adverse Outcome Pathway Framework: Case Study on Endocrine-Disrupting Chemicals with Estrogen and Androgen Receptors
por: Jeong, Jaeseong, et al.
Publicado: (2019)

Predicting molecular initiating events using chemical target annotations and gene expression
por: Bundy, Joseph L., et al.
Publicado: (2022)

Targeting Acetylcholinesterase: Identification of Chemical Leads by High Throughput Screening, Structure Determination and Molecular Modeling
por: Berg, Lotta, et al.
Publicado: (2011)

A Workflow to Investigate Exposure and Pharmacokinetic Influences on High-Throughput in Vitro Chemical Screening Based on Adverse Outcome Pathways
por: Phillips, Martin B., et al.
Publicado: (2015)

Patient stratification and identification of adverse event correlations in the space of 1190 drug related adverse events
por: Roitmann, Eva, et al.
Publicado: (2014)

Novel QSAR Models for Molecular Initiating Event Modeling in Two Intersecting Adverse Outcome Pathways Based Pulmonary Fibrosis Prediction for Biocidal Mixtures
por: Seo, Myungwon, et al.
Publicado: (2021)

Identification of serious, unpredictable adverse events with tocilizumab
Publicado: (2020)

Physico-Chemical Approaches to Investigate Surface Hydroxyls as Determinants of Molecular Initiating Events in Oxide Particle Toxicity
por: Pavan, Cristina, et al.
Publicado: (2023)

Molecular Initiating Events Associated with Drug-Induced Liver Malignant Tumors: An Integrated Study of the FDA Adverse Event Reporting System and Toxicity Predictions
por: Kurosaki, Kota, et al.
Publicado: (2021)

Keto-Bezoar: Adverse Event Related to Initiation of Ketogenic Diet in an Infant
por: Stegall, Cassandra, et al.
Publicado: (2022)

Identification of an adverse outcome pathway (AOP) for chemical-induced craniofacial anomalies using the transgenic zebrafish model
por: Liu, Shujie, et al.
Publicado: (2023)

A Toxicity Prediction Tool for Potential Agonist/Antagonist Activities in Molecular Initiating Events Based on Chemical Structures
por: Kurosaki, Kota, et al.
Publicado: (2020)

Annotation of primate miRNAs by high throughput sequencing of small RNA libraries
por: Dannemann, Michael, et al.
Publicado: (2012)

Metabolism-Disrupting Chemicals Affecting the Liver: Screening, Testing, and Molecular Pathway Identification
por: Fritsche, Kristin, et al.
Publicado: (2023)

A Computer Application to Predict Adverse Events in the Short-Term Evolution of Patients With Exacerbation of Chronic Obstructive Pulmonary Disease
por: Arostegui, Inmaculada, et al.
Publicado: (2019)

Adverse drug event presentation and tracking (ADEPT): semiautomated, high throughput pharmacovigilance using real-world data
por: Geva, Alon, et al.
Publicado: (2020)

High-throughput screening of antibody variants for chemical stability: identification of deamidation-resistant mutants
por: DiCara, Danielle M., et al.
Publicado: (2018)

Molecular methods in diagnostics of post-BCG vaccine adverse events
por: BRZEZIŃSKA, SYLWIA AGATA, et al.
Publicado: (2020)

COVID-19 vaccines adverse events: potential molecular mechanisms
por: Lamprinou, Malamatenia, et al.
Publicado: (2023)

Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
por: Fanaroff, Alexander C., et al.
Publicado: (2020)

Efficacy and adverse events related to the initial dose of methimazole in children and adolescents with Graves’ disease
por: Lee, Hyun Gyung, et al.
Publicado: (2021)

A prediction model for major adverse cardiovascular events in patients with heart failure based on high-throughput echocardiographic data
por: Sun, Qinliang, et al.
Publicado: (2022)

Hospital deaths and adverse events in Brazil
por: Martins, Mônica, et al.
Publicado: (2011)

The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment
por: Brockmeier, Erica K., et al.
Publicado: (2017)

sAOP: linking chemical stressors to adverse outcomes pathway networks
por: Aguayo-Orozco, Alejandro, et al.
Publicado: (2019)

Non-conveyance of older adult patients and association with subsequent clinical and adverse events after initial assessment by ambulance clinicians: a cohort analysis
por: Lederman, Jakob, et al.
Publicado: (2021)

Una función dieléctrica efectiva /
por: Lizano Soberón, Estela Susana
Publicado: (1981)

El nacimiento de los sistemas planetarios : discurso de ingreso (30 de noviembre de 2018) /
por: Lizano Soberón, Estela Susana
Publicado: (2019)

Molecular pathways driving omeprazole nephrotoxicity
por: Fontecha-Barriuso, Miguel, et al.
Publicado: (2020)

Characterization and Management of Hedgehog Pathway Inhibitor-Related Adverse Events in Patients With Advanced Basal Cell Carcinoma
por: Lacouture, Mario E., et al.
Publicado: (2016)

Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events
por: Yu, Yue, et al.
Publicado: (2016)

Adverse events in patients initiated on dabigatran etexilate therapy in a pharmacist-managed anticoagulation clinic
por: Donaldson, Mark, et al.
Publicado: (2013)

Incidents and adverse events notification system in a post-cardiac surgery unit. initial experience
por: Ruiz de Gopegui Miguelena, P, et al.
Publicado: (2015)

Random control selection for conducting high‐throughput adverse drug events screening using large‐scale longitudinal health data
por: Chiang, Chien‐Wei, et al.
Publicado: (2021)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Evaluating the risk of patient re-identification from adverse drug event reports
por: El Emam, Khaled, et al.
Publicado: (2013)

Using Twitter for the identification of COVID-19 vaccine-associated haematological adverse events
por: Bennett, Charles L, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cte5tdjg8m98btu5vd55u6mtai